Stay updated on Clinical Trial of IL-2 + Nivolumab in RCC
Sign up to get notified when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.

Latest updates to the Clinical Trial of IL-2 + Nivolumab in RCC page
- Check6 days agoChange DetectedRevision label on the page has been updated to v3.5.4, replacing the previous v3.5.3. This indicates a minor update to the page's documentation or release tagging, without altering study content or navigation.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page’s revision/version label was updated from **Revision: v3.5.2** to **Revision: v3.5.3**, indicating a technical or platform release rather than a change to the displayed clinical trial details.SummaryDifference0.1%

- Check34 days agoChange Detected- Revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; this change seems to be a software version update and does not modify the study details or how users interact with the page.SummaryDifference0.1%

- Check98 days agoChange DetectedRevision: v3.4.2 was added, and the broad government funding operating-status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Clinical Trial of IL-2 + Nivolumab in RCC
Enter your email address, and we'll notify you when there's something new on the Clinical Trial of IL-2 + Nivolumab in RCC page.